黄类药物在记忆丧失中的保护作用 - - 系统性综述
Regan Mujinya1,2, Swase Dominic Terkimbi3, Victor Otu Oka1
1Department of Physiology, Faculty of Biomedical sciences, Kampala International University - Western Campus, Bushenyi, Western Region, P.O Box. 71, Uganda.
F1000Research
|September 19, 2025
概括
黄类药物通过增强记忆力和减少氧化压力,有望保护人们免受记忆丧失. 这些天然化合物为认知障碍提供了潜在的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
- 生物化学 生物化学
背景情况:
- 失忆症是一种与神经退行,氧化应激和突触功能障碍相关的记忆障碍.
- 目前的失忆症治疗有效性和副作用有限.
- 来自自然来源的黄类化合物具有抗氧化,抗炎和神经营养特性,使其成为潜在的神经保护剂.
研究的目的:
- 系统地审查关于黄类药物在失忆症中的神经保护作用的实验证据.
- 阐明黄类药物对失忆症的作用机制,治疗结果和翻译潜力.
主要方法:
- 在科学网,Scopus和PubMed (2010-2024) 进行了系统的文献搜索.
- 研究查遵循了PRISMA 2020指南.
- 包括原始的实验研究,使用动物模型的记忆丧失治疗与黄类药物.
主要成果:
- 25项研究符合纳入标准,评估动物模型 (老鼠,老鼠,斑马鱼) 中的黄类.
- 黄类药物在行为测试中显著改善了认知表现 (莫里斯水迷宫,新型物体识别,Y-迷宫).
- 干预措施减少了氧化应激标志物 (MDA) 和增强了抗氧化防御 (GSH,SOD,CAT),调节神经保护基因 (BDNF,CREB1,Nrf2).
结论:
- 黄类药物通过增强的突触可塑性,减少氧化损伤和调节的亡来提供针对失忆症的多目标神经保护.
- 这些发现支持使用黄类药物治疗认知障碍的进展.
- 进一步的翻译研究和优化表述是有必要的.
相关概念视频
Role of Amygdala in Memory
1.1K
The amygdala is a small, almond-shaped structure responsible for processing and storing memories, particularly those linked to emotions like fear and stress. It plays an essential role in the brain's response to emotionally significant events and often enhances memory formation by triggering stress hormone release. The amygdala is vital for encoding and retrieving memories associated with fear or stress, a process that is adaptive by helping organisms avoid dangerous situations.
One of the...
One of the...
1.1K
Role of Neurotransmitters in Memory
2.5K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.5K
Amnesia
458
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
458
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Role of Cerebellum and Prefrontal Cortex in Memory
1.1K
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
1.1K
Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825


